Trial intelligence / Profile preview

Duac once-daily gel vs clindamycin gel in mild to moderate acne

CTR20132195Phase 3Completed

Sponsor
Stiefel Laboratories
Start
Jun 2014
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of clindamycin phosphate + benzoyl peroxide in acne vulgaris, sponsored by Stiefel Laboratories. Started Jun 2014; status: completed.

02

Drugs

clindamycin phosphate + benzoyl peroxide
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on CTR20132195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call